Neonatal disconnection of the rat hippocampus: A neurodevelopmental model of schizophrenia

Dialogues in Clinical Neuroscience

Volumn 4, Issue 4, 2002, Pages 361-367

  Lipska, Barbara K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DIZOCILPINE; DOPAMINE; EXCITOTOXIN; IBOTENIC ACID; N METHYL DEXTRO ASPARTIC ACID; NEUROLEPTIC AGENT; PHENCYCLIDINE; TETRODOTOXIN;

ADOLESCENCE; ADULTHOOD; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BEHAVIOR DISORDER; BRAIN DEVELOPMENT; BRAIN MATURATION; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; HIPPOCAMPUS; LOCOMOTION; NERVE CELL DIFFERENTIATION; NEUROANATOMY; NEUROBIOLOGY; NEWBORN; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PREPULSE INHIBITION; RAT; SCHIZOPHRENIA; STEREOTYPY; TARGET ORGAN;

EID: 0038669328     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (68)

1. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology. 1993;9:67-75.
2. 3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci. 1996;16:2020-2026.
3. Chambers RA, Moore J, McEvoy JP, Levin ED. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology. 1996;15:587-594.
4. Wan R-Q, Giovanni A, Kafka SH, Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav Brain Res. 1996;78:211-223.
5. Wan RQ, Hartman H, Corbett R. Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions. Physiol Behav. 1998;65:429-436.
6. Wan RQ, Corbett R. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology. 1997;16:259-268.
7. Brake WG, Sullivan RM, Flores G, Srivastava L, Gratton A. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the rat. Brain Res. 1999;831:25-32.
8. Black MD, Lister S, Hitchcock JM, Giersbergen P, Sorensen SM. Neonatal hippocampal lesion model of schizophrenia in rats: sex differences and persistence of effects into maturity. Drug Dev Res. 1998;43:206-213.
9. Becker A, Grecksch G, Bernsteinn HG, Hollt V, Bogerts B. Social behavior in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology. 1999;144:333-338.
10. Grecksch G, Bernstein HG, Becker A, Hollt V, Bogerts B. Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology. 1999;20:525-532.
11. Schroeder H, Grecksch G, Becker A, Bogerts B, Höllt V. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with post-natal ibotenic acid hippocampal lesion. Psychopharmacology. 1999;145:61-66.
12. Beauregard M, Bachevalier J. Neonatal insult to the hippocampal region and schizophrenia: a review and a putative animal model. Can J Psychiatry. 1996;41:446-456.
13. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: A proton magnetic resonance spectroscopic imaging study. Cereb Cortex. 1997;7:740-748.
14. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR. Neonatal lesions of the temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature. 1998;393:169-171.
15. Bachevalier J, Alvarado MC, Malkova L. Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood. Biol Psychiatry. 1999;46:329-339.
16. Falkai P, Bogerts B. Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci. 1986;236:154-161.
17. Murray RM, Lewis SW. Is schizophrenia a neurodevelopmental disorder? BMJ. 1987;295:681-682.
18. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660-669.
19. Jeste DV, Lohr JB. Hippocampal pathologic findings in schizophrenia: a morphometric study. Arch Gen Psychiatry. 1989;46:1019-1024.
20. Bogerts B, Ashtar M, Degreef G, Alvir JMJ, Bilder RM, Lieberman JA. Reduced temporal limbic structure volumes on magnetic resonance images in first-episode schizophrenia. Psychiatr Res Neuroimag. 1990;35:1-13.
21. Suddath RL, Christisin GW, Torrey EF, Casanova M, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med. 1990;322:789-794.
22. Eastwood SL, Burnet PW, Harrison PJ. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: a reverse transcriptase-polymerase chain reaction (RT-PCR) study. Brain Res Mol Brain Res. 1997;44:92-98.
23. Eastwood SL, McDonald B, Burnet PW, Beckwith JP, Kerwin RW, Harrison PJ. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia. Brain Res Mol Brain Res. 1995;29:211-223.
24. Eastwood SL, Harrison PJ. Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia. Neuroscience. 1998;86:437-448.
25. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry. 1999;45:395-402.
26. Jay TM, Glowinski J, Thierry AM. Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res. 1989;505:337-340.
27. Carr DB, Sesack SR. Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopaminergic terminals. J Comp Neurol. 1996;369:1-15.
28. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology. 2000;23:223-239.
29. Sams-Dodd F, Lipska BK, Weinberger DR. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology. 1997;132:303-310.
30. Lipska BK, Weinberger DR. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Brain Res Dev Brain Res. 1993;75:213-222.
31. Lipska BK, Weinberger DR. Subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology. 1994;10:199-205.
32. Lipska BK, Weinberger DR. Gonadectomy does not prevent novelty- or drug-induced hyperresponsiveness in rats with neonatal excitotoxic hippocampal damage. Dev Brain Res. 1994;78:253-258.
33. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes postpubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology. 1995;122:35-43.
34. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild chronic stress and haloperidol treatment. Synapse. 1995;20:125-130.
35. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology. 2002;27:47-54.
36. Al-Amin HA, Weinberger DR, Lipska BK. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav Pharmacol. 2000;11:269-278.
37. Al-Amin HA, Weickert CS, Weinberger DR, Lipska BK. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry. 2001;49:528-539.
38. Hori T, Subramaniam S, Carli M, Srivastava LK, Quirion R. Effects of repeated phencyclidine administration on locomotor activity and forced swimming test in rats with neonatal ventral hippocampal lesions. Soc Neurosci Abstr. 1999;635:8.
39. Lipska BK, Al-Amin HA, Weinberger DR. Excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology. 1998;19:451-464.
40. Lipska BK, Weinberger DR. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci USA. 1995;92:8906-8910.
41. Bertolino A, Roffman JL, Lipska BK, Van Gelderen P, Olson A, Weinberger DR. Reduced N-acetyl-aspartate in prefrontal cortex of adult rats with neonatal hippocampal damage. Cereb Cortex. 2002;12:983-990.
42. Lee CJ, Binder T, Lipska BK, et al. Neonatal ventral hippocampal lesions produce an elevation of Δ-FosB-like protein(s) in the rodent neocortex. Soc Neurosci Abstr. 1998;24:489.
43. Ashe P, Chlan-Fourney J, Juorio AV, Li XM, Boulton AA. Brain-derived neurotrophic factor mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Soc NeurosciAbstr. 1999;635:11.
44. O'Donnell P, Lewis BL, Lerman D, Weinberger DR, Lipska BK. Neonatal hippocampal damage alters electrophysiological properties of prefrontal cortical neurons. Cereb Cortex. 2002;12:975-982.
45. 1H-MRS signals. Neuropsychopharmacology. 2000;22:430-439.
46. Vanderschuren LJ, Schmidt ED, De Vries TJ, Van Moorsel CA, Tilders FJ, Schoffelmeer AN. A single exposure to amphetamine is sufficient to induce long-term behavioral, neuroendocrine, and neurochemical sensitization in rats. J Neurosci. 1999;19:9579-9586.
47. Gambarana C, Masi F, Tagliamonte A, Scheggi S, Ghiglieri O, De Montis MG. A chronic stress that impairs reactivity in rats also decreases dopaminergic transmission in the nucleus accumbens: a microdialysis study. J Neurochem. 1999;72:2039-2046.
48. 4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations. J Pharmacol Exp Ther. 1998;286:497-508.
49. Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
50. Bertolino A, Callicott JH, Elman I, et al. Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study. Biol Psychiatry. 1998;43:641-648.
51. Imperato A, Obinu MC, Carta G, Mascia MS, Casu MA, Gessa GL. Reduction of dopamine release and synthesis by repeated amphetamine treatment: role in behavioral sensitization. Eur J Pharmacol. 1996;317:231-237.
52. 123I]IBZM equilibrium SPECT measurement of amphetamine-induced dopamine release in rhesus monkeys exposed to subchronic amphetamine. Neuropsychopharmacology. 2000;22:4-13.
53. Steiner H, Gerfen CR. Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res. 1998;123:60-76.
54. Nestier EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science. 1997;278:58-63.
55. Lipska BK, Khaing ZZ, Lerman DN, Weinberger DR. Neonatal damage of the rat ventral hippocampus reduces expression of a dopamine transporter. Soc Neurosci Abstr. 1998;24:365.
56. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci. 1999;22:521-527.
57. Abi-Dargham A, Gil R, Krystal J, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry. 1998;155:761-767.
58. Laruelle M, Abi-Dargham A, van Dyck CH, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A. 1996;93:9235-9240.
59. Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci U S A. 1997;94:2569-2574.
60. Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci. 1997;17:8491-8497.
61. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65-73.
62. Lipska BK, Kolb B, Halim N, Weinberger DR. Synaptic abnormalities in prefrontal cortex and nucleus accumbens of adult rats with neonatal hippocampal damage. Schizophr Res. 2001;49:47.
63. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology. 1997;17:205-229.
64. Meng ZH, Feldpaush DL, Merchant KM. Clozapine and haloperidol block the induction of behavioral sensitization to amphetamine and associated genomic responses in rats. Brain Res Mol Brain Res. 1998;61:39-50.
65. Duncan GE, Sheitman BB, Lieberman JA. An integrated view of pathophysiological models of schizophrenia. Brain Res Brain Res Rev. 1999;29:250-264.
66. Sershen H, Harsing LG, Lipska BK, O'Donnell P. High Gly: role of glycine transporter in regulation of NMDA function. Thirty-fifth Annual Winter Conference on Brain Research, January 26-February 2, 2002. Snowmass Village, Colorado. Urbana-Champaign, III: Office of Continuing Education, University of Illinois at Urbana-Champaign. 2002:60. Abstract.
67. Bertolino A, Breier A, Callicott JH, et al. The relationship between dorsolateral prefrontal neuronal N-acetylaspartate and evoked release of striatal dopamine in schizophrenia. Neuropsychopharmacology. 2000;22:125-132.
68. Lipska BK, Halim ND, Segal PN, Weinberger DR. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci. 2002;22:2835-2842.